FIGURE

Fig. 1

ID

ZDB-FIG-250428-60

Publication

D'Aprile et al., 2025 - Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment

Other Figures

All Figure Page

Back to All Figure Page

Fig. 1

U-251 MG S, U-251 MG R and T98-G cells differently tolerate TMZ.

a Schematic representation of the protocol used to induce TMZ resistance in U-251 MG S cells. b–d LDH assay at 24 h on U-251 MG S (b), U-251 MG R (c) and T98-G (d) cells treated with 0, 50, 100, 250, 500 μM of TMZ. e–g Surviving fraction (SF) at 24 h and 72 h post-treatment, quantification of average clones size and representative pictures of the clonogenic assay at 72 h of U-251 MG S (e), U-251 MG R (f) and T98-G (g) clonogenic assay. Data are shown via scattered dot plots as mean ± SD of n ≥ 3 independent experiments. *p-value < 0.05; **p-value < 0.01; **** p-value < 0.0001. CTRL control, FC fold change, SF surviving fraction, TMZ temozolomide, Tx-100 Triton X-100.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Death Dis.